Author

Ceyda Llapashtica

Denali Therapeutics (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Assay:proteomics· 1 Assay:spatial transcriptomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Anastasia G. HenryiD· 1 shared Annie ArguelloiD· 1 shared Barbara CorneoiD· 1 shared Bianca MiglioriiD· 1 shared Bin XuiD· 1 shared Christoph KellendonkiD· 1 shared Elvira NegrouiD· 1 shared Francesco Gavino BrunduiD· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Anastasia G. HenryORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cortical Overgrowth in a Preclinical Forebrain Organoid Model of CNTNAP2-Associated Autism Spectrum Disorder

Job O. de Jong, Ceyda Llapashtica, Matthieu Genestine, Kevin A. Strauss, Frank A. Provenzano, Yan Sun, Huixiang Zhu, Giuseppe P. Cortese, Francesco Gavino Brundu, Karlla Welch Brigatti, Barbara Corneo, Bianca Migliori, Raju Tomer, Steven A. Kushner, Christoph Kellendonk, , Sander Markx

This study uses patient-derived forebrain organoids to investigate the effects of a CNTNAP2 mutation on cortical development, finding increased cell proliferation and differential gene expression associated with ASD.

Nature Communications · Sep 1, 2021Peer-reviewedNeuroscience

Understanding LRRK2 kinase activity in preclinical models and human subjects through quantitative analysis of LRRK2 and pRab10

Xiang Wang, Elvira Negrou, Michael T. Maloney, Vitaliy V. Bondar, Shan V. Andrews, Manuel Montalban, Ceyda Llapashtica, Romeo D. Maciuca, Hoang Ngan Nguyen, Hilda O. Solanoy, Annie Arguello, Laralynne Przybyla, Nathan J. Moerke, Sarah Huntwork, Anastasia G. Henry

The paper develops and applies quantitative assays to measure LRRK2 and pRab10 levels in cellular models and human subjects to assess LRRK2 kinase activity and its association with Parkinson's disease.

Scientific Reports · Jun 18, 2021Peer-reviewedNeuroscience